BioTime, XenneX deal

BioTime's LifeMap Sciences Inc. subsidiary will acquire XenneX in a stock deal. XenneX shareholders will receive 1.4 million shares, or about 13% common shares of LifeMap.

Read the full 261 word article

How to gain access

Continue reading with a
two-week free trial.